Publications by authors named "W Hoetzenecker"

Darier disease is a rare autosomal dominant genodermatosis caused by mutations in the ATP2A2 gene encoding for sarcoendoplasmic reticulum Ca ATPase isoform 2. The skin disease is characterized by a chronic relapsing course with recurrent reddish-brown keratotic papules and plaques located mainly in seborrhoeic areas. Due to chronic inflammation and epidermal barrier defects of the skin, patients often develop severe bacterial and viral superinfections.

View Article and Find Full Text PDF

Introduction: The clinical significance of elevated baseline serum tryptase (BST) in the absence of mast cell disorders or allergic reactions has long been unclear. Recently, a genetic variation of the gene, which among others encodes for alpha tryptase, has been reported and named hereditary alpha tryptasemia (HaT). HaT has been linked to various manifestations, including severe allergic reactions.

View Article and Find Full Text PDF
Article Synopsis
  • Cholingeric urticaria (CholU) involves varying skin reactions among patients, but these patterns are not well-defined or studied in terms of their impact.
  • A study identified six distinct types of CholU skin reactions, with most patients (94%) showing at least one type, while sweating issues were especially pronounced in those with certain types (like Type VI).
  • Type V reactions were found to correlate with the most severe disease presentation and highest quality of life impairment, indicating that different skin signs may reflect varying clinical features in CholU patients.
View Article and Find Full Text PDF

Programmed cell death 1 (PD-1) is a premier cancer drug target for immune checkpoint blockade (ICB). Because PD-1 receptor inhibition activates tumor-specific T-cell immunity, research has predominantly focused on T-cell-PD-1 expression and its immunobiology. In contrast, cancer cell-intrinsic PD-1 functional regulation is not well understood.

View Article and Find Full Text PDF
Article Synopsis
  • - Darier disease (DD) is a rare skin disorder caused by mutations in the ATP2A2 gene, which is essential for maintaining calcium balance in cells.
  • - Current research has shown that dantrolene sodium (Dl), a drug that typically treats other conditions, can increase calcium levels in the endoplasmic reticulum and improve cell adhesion in DD cells.
  • - The study indicates that Dl could help alleviate key issues related to DD by reducing endoplasmic reticulum stress and preventing cell death, suggesting it might be a viable treatment option for the disease.
View Article and Find Full Text PDF